Karen Wyckoff Rein in Sarcoma
Donations deductibleKaren Wyckoff Rein in Sarcoma's network
15 people1 organisationi15 people and 1 organisation on this map.The large node is the subject of this page. Solid lines are what the register itself records (15). Violet dotted lines (1) are likely: the same full name sits on the current board of another organisation in the same register and region. Form 990 filings give names without a person identifier; SEC insider filings carry a CIK. It may be a different person.The board
15 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations in the tables. The network map shows same-name matches as likely links only, never as confirmed.Tenure and departures are observed across annual filings. Observed tenure is a lower bound - a member may have joined before the first year on record. The organisation reported 14 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Aaron Halbe | Company secretary | 2020 | 6 yrs |
| Andrea Espejo Freire MD | Board Member | 2023 | 3 yrs |
| Blake Hastings | Board Member | 2020 | 6 yrs |
| Brendan Dillon | Board Member | 2021 | 5 yrs |
| Colin Ryan | Board Member | 2020 | 6 yrs |
| Conner O'Brien | Vice President | 2020 | 6 yrs |
| Dr David Largaespada | Board Member | 2023 | 3 yrs |
| Eric Lien | President | 2020 | 6 yrs |
| Jason Patalonis | Board Member | 2022 | 4 yrs |
| John Charlson MD | Board Member | 2020 | 6 yrs |
| Laura Gagne | Board Member | 2023 | 3 yrs |
| Maureen Anderson DNP | Board Member | 2022 | 4 yrs |
| Mitch Atherton | Treasurer | 2020 | 6 yrs |
| Scott Okuno MD | Board Member | 2020 | 6 yrs |
| Stephanie Terezakis MD | Board Member | 2020 | 6 yrs |
Officers and senior leadership
2 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Janelle Calhoun | Executive Director | since 2020 |
| Lachelle Semanko | Executive Director | since 2023 |
Pay and hours
year to 31 December 2024iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Lachelle Semanko | Executive Director | 40 | $115k | $6k | |
| Scott Okuno MD | Board Member | 1 | $0 | ||
| Colin Ryan | Board Member | 1 | $0 | ||
| Maureen Anderson DNP | Board Member | 1 | $0 | ||
| Laura Gagne | Board Member | 1 | $0 | ||
| Jason Patalonis | Board Member | 1 | $0 | ||
| Brendan Dillon | Board Member | 1 | $0 | ||
| Stephanie Terezakis MD | Board Member | 1 | $0 | ||
| Andrea Espejo Freire MD | Board Member | 1 | $0 | ||
| John Charlson MD | Board Member | 1 | $0 | ||
| Dr David Largaespada | Board Member | 1 | $0 | ||
| Blake Hastings | Board Member | 1 | $0 | ||
| Eric Lien | President | 2 | $0 | ||
| Conner O'Brien | Vice President | 2 | $0 | ||
| Mitch Atherton | Treasurer | 1 | $0 | ||
| Aaron Halbe | Secretary | 1 | $0 |
About
- Legal name
- Karen Wyckoff Rein in Sarcoma
- EIN
- 200811343
- Address
- 7401 Central Ave Ne Ste 1, Fridley, MN, 55432-3572
- State
- Minnesota
- Mission
- Our three-pronged mission: educating the public and medical community about sarcomas, supporting sarcoma patients and their loved ones, and funding research directed toward developing new treatments and finding a cure for sarcoma cancers. (as filed on the Form 990)
- Activity (NTEE)
- H30 Medical research
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Medical Research
- Size band
- 6 (IRS master file code)
- Formed
- 2004
- Principal officer
- Mitch Atherton (as named on the Form 990)
- IRS ruling date
- 1 May 2004
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 5, latest 2024
- IRS Publication 78
- PC (contributions deductible)
Most connected
Longest observed on the filings
≥6years on the filingsAaron Halbe
≥6years on the filingsBlake Hastings
≥6years on the filingsColin Ryan
≥6years on the filingsConner O'Brien
Latest return
year to 31 December 2024iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2024. US dollars, as filed.- Total assets
- $1.1m
- Total liabilities
- $56k
- Net assets or fund balances
- $1m
- Contributions and grants received
- $540k
- Program service revenue
- $5k
- Grants and similar paid out
- $210k
- Employees
- 4
- Volunteers
- 117
Filed finances
1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.| Tax year | Total revenue | Total expenses | Surplus or deficit |
|---|---|---|---|
| 2024 | $577k | $697k | Deficit $120k |
As filed on the IRS Form 990. US dollars.
Grants paid
5 listediFrom Schedule I of the Form 990: grants and assistance to organisations in the United States, largest first (up to 25). Schedule I is filed only by organisations that gave more than $5,000 to any one recipient.| Recipient | Purpose | Amount |
|---|---|---|
| Aveni Foundation | Sarcoma Research | $77k |
| University of Minnesota Foundation | Sarcoma Research & educating medical students about Sarcoma, who, in turn, educate peers with long-lasting impact. | $63k |
| University of Michigan | Sarcoma Research & educating medical students about Sarcoma, who, in turn, educate peers with long-lasting impact. | $8k |
| University of Wisconsin Foundation | Educating medical students about Sarcoma, who, in turn, educate peers with long-lasting impact. | $6k |
| Mayo Clinic | Return of Sarcoma Research funds awarded in 2023 | Minus $13k |